Under the liquidity contract entrusted by Innate Pharma to Natixis Securities, the following assets appeared on the liquidity account as at December 31, 2009:

• 69,741 shares of Innate Pharma, and
• 121,955.05 euros in cash.

For information, the following assets appeared on the liquidity account at its start:

• 300,000 euros in cash